Sales rise 53.51% to Rs 21.43 crore
Net loss of Concord Drugs reported to Rs 1.78 crore in the quarter ended March 2017 as against net profit of Rs 0.53 crore during the previous quarter ended March 2016. Sales rose 53.51% to Rs 21.43 crore in the quarter ended March 2017 as against Rs 13.96 crore during the previous quarter ended March 2016.For the full year,net profit declined 90.86% to Rs 0.16 crore in the year ended March 2017 as against Rs 1.75 crore during the previous year ended March 2016. Sales rose 13.44% to Rs 57.49 crore in the year ended March 2017 as against Rs 50.68 crore during the previous year ended March 2016.
ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales21.4313.96 54 57.4950.68 13 OPM %-3.5011.17 -9.5516.26 - PBDT-1.431.02 PL 3.225.87 -45 PBT-2.150.39 PL 0.642.96 -78 NP-1.780.53 PL 0.161.75 -91
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
